Cardiovascular Diseases Clinical Trial
To conduct a randomized controlled trial to evaluate the effectiveness of an intervention to reduce dietary fat.
BACKGROUND:
The African-American population of the United States continues to experience high rates of
mortality from cardiovascular (CV) disease, including coronary heart disease, stroke and
renal failure. The major syndromes which determine CV risk, including obesity,
hypercholesterolemia, glucose intolerance, and hypertension, all occur more frequently among
African Americans. Nutritional factors underlie many forms of CV disease and are an
important focus of current prevention efforts. Very little is currently known, however,
about specific nutritional patterns among African Americans that might lead to CV risk, or
the applicability of structured interventions.
The study was conducted in response to an initiative on "Collaborative Projects on Minority
Health" which was released in October 1992 after review and approval at the September 1992
National Heart, Lung, and Blood Advisory Council.
DESIGN NARRATIVE:
Given the growing recognition of the importance of total fat, from the point of view of both
disease risk and eating patterns, the primary focus of the intervention was to reduce the
percentage of calories in the diet from fat. Four hundred households were recruited and
randomly assigned to either an active intervention or observation group for a period of 18
months. Dietary change consistent with specific recommendations made to the American public
for reducing cardiovascular (CV) risk was encouraged, namely, reduction in total fat,
saturated fat (SFA), and cholesterol (Chol). A practical, community-based program was
developed which could be taken into households. Nutrition education and enhancement of
skills helpful in making behavioral change formed the basis of the intervention. Lay
educators, recruited from the target neighborhoods, worked under the close supervision of a
community nutritionist. Changes in reported dietary intake, serum lipids/lipoproteins and
body weights were measured. In addition to the formal evaluation of the trial outcome, an
important secondary goal was to obtain detailed information about eating patterns in this
community and characterize behavior associated with the achievement and maintenance of
target nutrient goals.
The study was part of a collaborative project on minority health. Dr. Prewitt collaborated
with Dr. Marian Fitzgibbon who was the principal investigator on R01HL51532.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|